Page last updated: 2024-08-17

kanamycin a and Tuberculosis, Drug-Resistant

kanamycin a has been researched along with Tuberculosis, Drug-Resistant in 115 studies

Research

Studies (115)

TimeframeStudies, this research(%)All Research%
pre-19904 (3.48)18.7374
1990's3 (2.61)18.2507
2000's17 (14.78)29.6817
2010's68 (59.13)24.3611
2020's23 (20.00)2.80

Authors

AuthorsStudies
Chopra, S; Dusthackeer, VNA; Krishna, EV; Krishna, VS; Mahizhaveni, B; Makane, VB; Misra, S; Rode, HB; Shukla, M; Sriram, D1
Chen, S; Ding, CZ; Franzblau, SG; Guo, F; Huang, Z; Li, L; Li, Y; Luo, W; Shen, L; Tang, D; Wang, B; Xu, D; Yang, M; Zhu, Y1
Bin, W; Chen, S; Ding, CZ; Franzblau, SG; Hu, Y; Huang, Z; Jiang, N; Luo, W; Shen, L; Tao, X; Wei, X; Wei, Y; Xu, D; Yang, M; Zhu, Y1
Barilar, I; Cirillo, DM; Farhat, MR; Freschi, L; Köser, CU; Miotto, P; Niemann, S; Spitaleri, A; Tahseen, S; Vargas, R1
Bhalla, M; Ciobanu, N; Conradie, F; Crudu, V; David, A; Denkinger, CM; Georghiou, SB; Kazi, M; Myneedu, VP; Penn-Nicholson, A; Rodrigues, C; Ruhwald, M; Schumacher, SG; Scott, L1
Ahmed, S; Banu, S; Khatun, R; Nasrin, R; Rahman, A; Rahman, MM; Rahman, SMM; Uddin, MKM1
Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F1
Gui, X; Sun, W; Wu, Z; Yan, L; Zhang, Y1
Alarcón, MJ; Coronel, J; Cotrina, VV; Moore, DAJ; Puyén, ZM; Santos-Lázaro, D; Vigo, AN1
Doustdar, F; Eslami, G; Ghalavand, Z; Habibnia, S; Karami-Zarandi, M; Kazemian, H; Zaker, S1
Catanzaro, A; Catanzaro, DG; Chiles, P; Ciobanu, N; Codreanu, A; Colman, RE; Cooney, CG; Crudu, V; Hillery, N; Holmberg, RC; Kukhtin, AV; Linger, Y; Norville, R; Rodwell, TC; Seifert, M; Syed, RR1
Dou, X; Lu, J; Pan, Y; Yi, Y; Yu, Y; Zhou, L1
Berge, I; Bogdanova, I; Freimane, L; Norvaiša, I; Ozere, I; Ranka, R; Sadovska, D; Vaivode, A; Vīksna, A1
Garneau-Tsodikova, S; Green, KD; Hou, C; Punetha, A; Tsodikov, OV1
Gebreyes, W; Gelaw, B; Robinson, R; Shibabaw, A; Tessema, B; Wang, SH1
Balkissou Adamou, D; Kuaban, C; Pefura-Yone, EW; Poka-Mayap, V1
Budhathoki, C; Dooley, KE; Dowdy, DW; Farley, JE; Francis, HW; Han, HR; Hong, H1
Chaiprasert, A; Chongsuvivatwong, V; Faksri, K; Kaewprasert, O; Kusumawati, RL; Pratama, WA; Regmi, SM; Rukmana, A; Sudarmono, P; Tania, T1
Affolabi, D; de Jong, BC; Decroo, T; Dusabe, T; Habimana, YM; Migambi, P; Mulders, W; Ngabonziza, JCS; Niyigena, EB; Rigouts, L; Supply, P; Ushizimpumu, B; Van Deun, A1
Jafari, R; Moghim, S; Nasr Esfahani, B; Safari, M; Salehi, M1
Jain, AK; Sharma, P1
Achar, J; Azamat, I; Bayram, H; Gil, H; Gomez, D; Margaryan, H; Nazirov, P; Parpieva, N; Singh, J; Zayniddin, S; Ziba, B1
Ji, Y; Li, Z; Liu, Q; Martinez, L; Qiu, B; Song, H; Wang, J; Yang, D1
Khoza-Shangase, K; Prodromos, M1
Barry, CE; Carter, CL; Dartois, V; Ernest, JP; Gengenbacher, M; Kaya, F; Sarathy, J; Savic, RM; Strydom, N; Via, LE; Wang, H; Wang, N; Xie, M; Zimmerman, MD1
Das, SC; Doyle, C; Momin, MAM; Sinha, S; Tucker, IG1
Bablishvili, N; Blumberg, HM; Gandhi, NR; Kempker, RR; Mathema, B; Shashkina, E; Tukvadze, N1
Cao, G; Chen, X; Dai, J; Fu, ZF; Habib, Z; Jamal, M; Rehman, K; Xu, W1
Aono, A; Chikamatsu, K; Igarashi, Y; Mitarai, S; Takaki, A; Yamada, H; Yi, L1
Chen, Y; Liang, YP; Liu, HC; Wan, KL; Xia, Q; Xiao, TY; Zeng, CY; Zhao, LL; Zhao, XQ1
Andres, S; Beckert, P; Heyckendorf, J; Hillemann, D; Kohl, TA; Köser, CU; Lange, C; Merker, M; Moradigaravand, D; Niemann, S; Olaru, ID; Parkhill, J; Peacock, SJ; Schleusener, V; Schön, T; Sturegård, E1
Leufkens, HGM; Mantel-Teeuwisse, AK; Mavhunga, F; Mekonen, TT; Mengistu, A; Rennie, T; Ruswa, N; Sagwa, EL1
Ahmed, S; Akhanda, MW; Banu, S; Ebers, A; Gleason, AT; Heysell, SK; Houpt, ER; Rahman, MT1
Bourkadi, JE; Chaoui, I; Chetioui, F; El Mzibri, M; Elmessaoudi, MD; Karimi, H; Laglaoui, A; Oudghiri, A; Zakham, F1
Behera, D; Kaur, P; Saini, A; Sethi, S; Yadav, R1
Ihm, C; Kim, K; Park, J; Park, K; Shin, S; Shin, SY1
Abdelghani, N; Dawood, H; Naidoo, K; Naidu, N; Padayatchi, N; Perumal, R; Singh, N; Yende-Zuma, N1
Chhabra, M; Jangra, MS1
Chirehwa, MT; Court, RG; de Vries, N; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Stewart, A; Wiesner, L1
Chaiprasert, A; Phunpruch, S; Prammananan, T; Sowajassatakul, A1
Govindaswamy, A; Jeyaseelan, L; Michael, JS; Pai, R; Sakthi, D1
Ahmad, N; Ahuja, SD; Akkerman, OW; Alffenaar, JC; Anderson, LF; Baghaei, P; Bang, D; Barry, PM; Bastos, ML; Behera, D; Benedetti, A; Bisson, GP; Boeree, MJ; Bonnet, M; Brode, SK; Brust, JCM; Cai, Y; Caumes, E; Cegielski, JP; Centis, R; Chan, ED; Chan, PC; Chang, KC; Charles, M; Cirule, A; D'Ambrosio, L; Dalcolmo, MP; de Vries, G; Dheda, K; Esmail, A; Flood, J; Fox, GJ; Fréchet-Jachym, M; Fregona, G; Gayoso, R; Gegia, M; Gler, MT; Gu, S; Guglielmetti, L; Holtz, TH; Hughes, J; Isaakidis, P; Jarlsberg, L; Kempker, RR; Keshavjee, S; Khan, FA; Kipiani, M; Koenig, SP; Koh, WJ; Kritski, A; Kuksa, L; Kvasnovsky, CL; Kwak, N; Lan, Z; Lange, C; Laniado-Laborín, R; Lee, M; Leimane, V; Leung, CC; Leung, EC; Li, PZ; Lowenthal, P; Maciel, EL; Marks, SM; Mase, S; Mbuagbaw, L; Menzies, D; Migliori, GB; Milanov, V; Miller, AC; Mitnick, CD; Modongo, C; Mohr, E; Monedero, I; Nahid, P; Ndjeka, N; O'Donnell, MR; Padayatchi, N; Palmero, D; Pape, JW; Podewils, LJ; Reynolds, I; Riekstina, V; Robert, J; Rodriguez, M; Schnippel, K; Seaworth, B; Seung, KJ; Shim, TS; Singla, R; Smith, SE; Sotgiu, G; Sukhbaatar, G; Tabarsi, P; Tiberi, S; Trajman, A; Trieu, L; Udwadia, ZF; van der Werf, TS; Veziris, N; Viiklepp, P; Vilbrun, SC; Walsh, K; Westenhouse, J; Yew, WW; Yim, JJ; Zetola, NM; Zignol, M1
Cao, P; Doan, TN; Emeto, TI; McBryde, ES; McCaw, JM1
Bastard, M; DuCros, P; Galindo, MA; Mahinça, I; Molfino, L; Mutaquiha, C; Rusch, B; Telnov, A; Vaz, D; Zindoga, P1
Amukoye, E; Nonoh, J; Nyamache, AK; Ogari, CO1
Bang, H; Barry, CE; Dartois, V; Eum, S; Fox, WS; Gupta, SV; Lee, M; Savic, RM; Shim, T; Strydom, N; Via, LE; Zimmerman, M1
Bisht, D; Faheem, M; Joshi, B; Khan, AU; Lata, M; Sharma, D; Shukla, S; Venkatesan, K1
Admasu, A; Berha, AB; Negash, Z; Sheth, AN; Shibeshi, W; Yimer, G1
Abdi, H; Arube, P; Dlamini, MG; Joloba, ML; Kamulegeya, R; Kasule, GW; Katabazi, FA; Kateete, DP; Khumalo, D; Kigozi, E; Lukoye, D; Musisi, K; Sebit, SI1
Choe, KH; Chung, GT; Hwang, SC; Jnawali, HN; Kim, H; Lee, YS; Park, YK; Ryoo, S1
Duarte, R; Gaio, R; Oliveira, O; Villar, M1
Alcántara, F; Atwood, SS; Becerra, MC; Bonilla, CA; Mitnick, CD; Seung, KJ1
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S1
Chen, Y; Li, GL; Liu, HC; Liu, ZG; Sun, Q; Wan, KL; Wu, XC; Xia, Q; Zhao, LL; Zhao, XQ1
Ajbani, K; Catanzaro, A; Caviedes, L; Coronel, J; Crudu, V; Desmond, E; Eisenach, K; Ganiats, TG; Garfein, RS; Groessl, EJ; Jackson, RL; Klages, S; Moore, D; Rodrigues, C; Rodwell, TC; Romancenco, E; Trollip, AP; Victor, T; Vineet, VP1
Apsindzelashvili, R; Bablishvili, N; Blumberg, HM; Kempker, RR; Tukvadze, N1
Kam, KM; Liu, M; Pang, Y; Wang, Y; Zhang, Z; Zhao, Y1
Liu, B; Pang, Y; Wang, Y; Zhang, D1
Chiang, CY; Madan, J; Meredith, SK; Nunn, AJ; Phillips, PP; Rusen, ID; Squire, SB; Torrea, G; Van Deun, A1
Aung, KJ; Das, PK; Declercq, E; Hossain, MA; Rieder, HL; Sarker, MR; Van Deun, A1
Boukary, I; Daouda, M; Hanki, Y; Harouna, SH; Morou, S; Piubello, A; Souleymane, MB; Van Deun, A1
Campbell, PJ; Posey, JE; Reeves, AZ; Willby, MJ1
Bharti, H; Bhushan, B; Chander, R; Gupta, A; Kajal, NC; Ranga, V1
Cesur, S; Şimşek, H; Tarhan, G1
Abena Foe, JL; Aït-Khaled, N; Kuaban, C; Noeske, J; Rieder, HL; Trébucq, A1
Akkerman, OW; Alffenaar, JW; de Lange, WC; Dijkstra, JA; Kosterink, JG; Proost, JH; van Altena, R; van der Werf, TS1
Huang, H; Ke, Z; Liu, S; Mao, X; Shi, X; Tang, B; Wang, J1
Leufkens, HG; Mantel-Teeuwisse, AK; Mavhunga, F; Rennie, T; Ruswa, N; Sagwa, EL1
Anand, S; Gupta, P; Jain, A; Kaur, A; Kaur, S; Rana, V; Sharma, C; Singh, P; Trivedi, G1
Sibbald, B1
Ajbani, K; Catanzaro, A; Georghiou, SB; Kambli, P; Nikam, C; Rodrigues, C; Rodwell, TC; Sadani, M; Shetty, A; Udwadia, Z1
Aubry, A; Brossier, F; Guindo, D; Pham, A; Reibel, F; Sougakoff, W; Veziris, N1
Catanzaro, A; Catanzaro, D; Crudu, V; Garfein, RS; Georghiou, SB; Rodrigues, C; Rodwell, TC; Seifert, M; Valafar, F; Victor, TC1
Cai, X; Deng, Y; Dong, H; Huan, S; Jing, H; Li, J; Li, Q; Li, X; Ou, X; Pang, Y; Su, B; Tan, Y; Xia, H; Zhang, J; Zhang, Z; Zhao, Y1
Dixit, P; Jain, A; Jaiswal, I; Singh, M; Singh, P; Singhal, P1
Hosmane, GB; Jain, A; Kushwaha, RA; Prasad, R; Singh, A; Srivastava, R1
Garcia-Prats, AJ; Hesseling, AC; Schaaf, HS1
Karak, A; Mukhopadhay, S; Paul, R; Santra, G1
Aldaba, JG; Ama, CG; Geraldino, XD; Lopez, AL; Salonga, AM; Sarol, JN; Sylim, PG1
Adebola, SO; Adedeji, TO; Adefuye, BO; Oladeji, SM; Sogebi, OA1
Aubry, A; Bernard, C; Brossier, F; Jarlier, V; Pham, A; Sougakoff, W; Veziris, N1
Li, C; Sugawara, I; Zhang, J1
Chadha, S; Chandrasekar, V; Chauhan, LS; Dave, PV; Dewan, P; Nalini, S; Narayanan, PR; Paramasivan, CN; Parmar, M; Ramachandran, R; Sahu, S; Sanghvi, AS; Wares, F1
Bzekalava, N; de Rijk, P; Fissette, K; Jugheli, L; Portaels, F; Rigouts, L1
Metchock, B; Posey, JE; Shinnick, TM; Sikes, RD; Zaunbrecher, MA1
Desai, VB; Fredrick, JS; Joseph, P; Mohan, NS; Ramachandran, R; Raman, B; Thomas, A; Wares, F1
Baba, K; Ehlers, MM; Hoosen, AA; Ismail, NA; Kock, MM; Omar, SV; Osman, AG; Said, HM1
de Rijk, P; Fissette, K; Martin, A; Palomino, JC; Ramos, E1
Li, HM; Liang, JQ; Liu, CH; Wang, Q; Yang, N; Yu, HT1
Catanzaro, A; Catanzaro, DG; Garfein, RS; Georghiou, SB; Magana, M; Rodwell, TC1
Hassan, G; Kant, S; Parengal, J; Saheer, S1
Baba, K; Ehlers, MM; Hoosen, AA; Ismail, NA; Kock, MM; Mphahlele, M; Omar, SV; Osman, AG; Said, HM1
Kumar, V; Lakshmi, R; Rahman, F; Ramachandran, R1
Dixit, P; Jain, A; Prasad, R1
Allen, J; Bassett, IV; Chetty, S; Freedberg, KA; Giddy, J; Hom, JK; Losina, E; Mazibuko, M; Walensky, RP; Wang, B1
Chen, TP; Chen, YH; Hwang, KP; Lee, YW; Lu, PL; Peng, CF; Tsai, JJ1
SHIGEMATSU, T1
BLALOCK, FA; CORPE, RF; GOLDHAMMER, EJ; GROSS, JH1
ALLISON, RF; INGLIS, RM; SCHLESS, JM; TOPPERMAN, S; WHITE, EF1
Novozhylova, IO1
Kondakova, MN; Pavlova, MV; Sapozhnikova, NV; Skvortsova, LA1
Han, L; Lee, DH; Lee, WC; Mitnick, CD; Park, SK; Seung, KJ1
Belianin, II; Shmelev, EI2
Andrianasolo, D; Ramarokoto, H; Ramaroson, F; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsimba, L; Razafitsiarovana, I; Vincent, V1
Ovsiankina, ES; Panova, LV1
Dediste, A; Portaels, F; Rigouts, L; Shamputa, IC; Struelens, M; Umubyeyi, A1
Chaisuksuwan, R; Pransujarit, V; Punnotok, J; Riantawan, P1
Pei, X; Yang, Y; Ye, Z1
Chan, CY; Chau, CH; Cheng, AF; Cheung, SW; Leung, CK; Wong, CF; Yew, WW1
Naumov, VN; Shaĭkhaev, AIa1
Kohno, S; Oka, M; Sohda, H; Tsurutani, J1
Arora, VK; Gupta, R; Gupta, S; Singla, R1
de Jager, P; van Altena, R1

Reviews

5 review(s) available for kanamycin a and Tuberculosis, Drug-Resistant

ArticleYear
Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis.
    Antimicrobial agents and chemotherapy, 2021, 09-17, Volume: 65, Issue:10

    Topics: Animals; Antitubercular Agents; Humans; Kanamycin; Mycobacterium tuberculosis; Rabbits; Randomized Controlled Trials as Topic; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2021
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
    Lancet (London, England), 2018, 09-08, Volume: 392, Issue:10150

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Carbapenems; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Linezolid; Moxifloxacin; Recurrence; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2018
Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol with Genotype MTBDRsl Assay: a Meta-Analysis.
    Annals of clinical and laboratory science, 2015,Fall, Volume: 45, Issue:5

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genotyping Techniques; Humans; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2015
The safety and tolerability of the second-line injectable antituberculosis drugs in children.
    Expert opinion on drug safety, 2016, Volume: 15, Issue:11

    Topics: Adult; Amikacin; Animals; Antitubercular Agents; Capreomycin; Child; Drug Monitoring; Humans; Injections; Kanamycin; Risk Factors; Tuberculosis, Multidrug-Resistant

2016
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review.
    PloS one, 2012, Volume: 7, Issue:3

    Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Methyltransferases; Mutation; Mycobacterium tuberculosis; Promoter Regions, Genetic; Tuberculosis, Multidrug-Resistant

2012

Trials

6 trial(s) available for kanamycin a and Tuberculosis, Drug-Resistant

ArticleYear
Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2018, 08-01, Volume: 22, Issue:8

    Topics: Adult; Anesthetics, Local; Anti-Bacterial Agents; Cross-Over Studies; Female; HIV Infections; Humans; Injections, Intramuscular; Kanamycin; Lidocaine; Logistic Models; Male; Middle Aged; Pain Measurement; Pain, Procedural; Single-Blind Method; South Africa; Tuberculosis, Multidrug-Resistant

2018
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trial.
    Trials, 2014, Sep-09, Volume: 15

    Topics: Antitubercular Agents; Bangladesh; Clinical Protocols; Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Moxifloxacin; Prothionamide; Pyrazinamide; Research Design; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2014
Outcome of standardized treatment for patients with MDR-TB from Tamil Nadu, India.
    The Indian journal of medical research, 2011, Volume: 133

    Topics: Adult; Antibiotics, Antitubercular; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Ethionamide; Female; Humans; India; Kanamycin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pyrazinamide; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2011
[Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients].
    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 1997, Volume: 20, Issue:4

    Topics: Adult; Aminosalicylic Acid; Anti-Infective Agents; Antitubercular Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kanamycin; Male; Middle Aged; Ofloxacin; Prothionamide; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

1997
Serum pharmacokinetics of antimycobacterial drugs in patients with multidrug-resistant tuberculosis during therapy.
    International journal of clinical pharmacology research, 1999, Volume: 19, Issue:3

    Topics: Adult; Amikacin; Antitubercular Agents; Female; Humans; Kanamycin; Male; Middle Aged; Tuberculosis, Multidrug-Resistant

1999
Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2001, Volume: 5, Issue:6

    Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Culture Media; Dermatitis, Phototoxic; Drug Therapy, Combination; Ethionamide; Fluoroquinolones; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2001

Other Studies

104 other study(ies) available for kanamycin a and Tuberculosis, Drug-Resistant

ArticleYear
Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
    European journal of medicinal chemistry, 2019, Feb-15, Volume: 164

    Topics: Amides; Animals; Antitubercular Agents; Cell Line; Chemistry, Pharmaceutical; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2019
Discovery and preclinical profile of sudapyridine (WX-081), a novel anti-tuberculosis agent.
    Bioorganic & medicinal chemistry letters, 2022, 09-01, Volume: 71

    Topics: Animals; Antitubercular Agents; Long QT Syndrome; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2022
Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent.
    Bioorganic & medicinal chemistry letters, 2022, 09-15, Volume: 72

    Topics: Antitubercular Agents; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2022
Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex.
    Antimicrobial agents and chemotherapy, 2021, 10-18, Volume: 65, Issue:11

    Topics: Amikacin; Antitubercular Agents; Clofazimine; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Epistasis, Genetic; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2021
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study.
    The Lancet. Infectious diseases, 2022, Volume: 22, Issue:2

    Topics: Adult; Amikacin; Australia; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis; Tuberculosis, Multidrug-Resistant

2022
Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
    PloS one, 2021, Volume: 16, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bangladesh; DNA, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Female; Genotype; Genotyping Techniques; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant

2021
Use of Whole-Genome Sequencing to Predict
    Microbiology spectrum, 2022, 04-27, Volume: 10, Issue:2

    Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant

2022
Prediction of drug resistance profile of multidrug-resistant Mycobacterium tuberculosis (MDR-MTB) isolates from newly diagnosed case by whole genome sequencing (WGS): a study from a high tuberculosis burden country.
    BMC infectious diseases, 2022, May-27, Volume: 22, Issue:1

    Topics: Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing

2022
Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru.
    BMC infectious diseases, 2022, Aug-24, Volume: 22, Issue:1

    Topics: Antitubercular Agents; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peru; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant

2022
Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis.
    Clinical laboratory, 2023, Jan-01, Volume: 69, Issue:1

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Iran; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2023
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.
    Journal of clinical microbiology, 2023, 03-23, Volume: 61, Issue:3

    Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant

2023
The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study.
    BMC infectious diseases, 2023, Mar-15, Volume: 23, Issue:1

    Topics: Antitubercular Agents; China; Diabetes Mellitus; Drug Resistance; Extensively Drug-Resistant Tuberculosis; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Tuberculosis, Multidrug-Resistant

2023
Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
    BMC infectious diseases, 2023, Sep-28, Volume: 23, Issue:1

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Latvia; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing

2023
Probing the Robustness of Inhibitors of Tuberculosis Aminoglycoside Resistance Enzyme Eis by Mutagenesis.
    ACS infectious diseases, 2019, 10-11, Volume: 5, Issue:10

    Topics: Acetylation; Acetyltransferases; Aminoglycosides; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Binding Sites; Drug Resistance, Bacterial; Enzyme Inhibitors; Kanamycin; Kinetics; Models, Molecular; Mutagenesis; Mutation; Mycobacterium tuberculosis; Protein Conformation; Tuberculosis; Tuberculosis, Multidrug-Resistant

2019
The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
    PloS one, 2020, Volume: 15, Issue:2

    Topics: Adult; Antitubercular Agents; Chi-Square Distribution; Cross-Sectional Studies; Ethiopia; Extensively Drug-Resistant Tuberculosis; Female; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Tuberculosis, Multidrug-Resistant; Young Adult

2020
[Kanamycin-induced ototoxicity during treatment of multidrug-resistant tuberculosis].
    Revue des maladies respiratoires, 2020, Volume: 37, Issue:5

    Topics: Adult; Aminoglycosides; Antitubercular Agents; Cameroon; Female; Hearing Loss; Humans; Incidence; Kanamycin; Male; Ototoxicity; Retrospective Studies; Tuberculosis, Multidrug-Resistant

2020
Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa.
    American journal of audiology, 2020, Jun-08, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Audiometry; Auditory Threshold; Cross-Sectional Studies; Female; Hearing Loss; HIV Infections; Humans; Hypoalbuminemia; Kanamycin; Male; Middle Aged; Ototoxicity; Prevalence; Renal Insufficiency; South Africa; Thinness; Tuberculosis, Multidrug-Resistant; Young Adult

2020
Whole-genome sequencing analysis of multidrug-resistant
    Journal of medical microbiology, 2020, Volume: 69, Issue:7

    Topics: Adult; Antitubercular Agents; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Indonesia; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Mutation; Mycobacterium tuberculosis; Phenotype; Phylogeny; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing

2020
Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis.
    The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:4

    Topics: Antitubercular Agents; Clofazimine; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Genes, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Kanamycin; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Rwanda; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant

2020
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2020, Volume: 85

    Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genetic Variation; Genotype; Humans; Iran; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant

2020
Ethionamide induced blue vision (cyanopsia): Case report.
    The Indian journal of tuberculosis, 2020, Volume: 67, Issue:3

    Topics: Aminosalicylic Acid; Antitubercular Agents; Color Vision Defects; Cycloserine; Ethionamide; Female; Humans; Kanamycin; Linezolid; Moxifloxacin; Tuberculosis, Multidrug-Resistant; Young Adult

2020
Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan.
    Tropical medicine & international health : TM & IH, 2021, Volume: 26, Issue:4

    Topics: Antibiotics, Antitubercular; Capreomycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Uzbekistan

2021
Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China.
    PLoS neglected tropical diseases, 2021, Volume: 15, Issue:1

    Topics: Acetyltransferases; Adult; Amidohydrolases; Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Multivariate Analysis; Mutation; Mutation Rate; Mycobacterium tuberculosis; Odds Ratio; Ofloxacin; Prospective Studies; Rifampin; Sequence Analysis, DNA; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2021
Impact of drug-resistant tuberculosis treatment on hearing function in South African adults: Bedaquiline versus kanamycin.
    The South African journal of communication disorders = Die Suid-Afrikaanse tydskrif vir Kommunikasieafwykings, 2021, Jan-26, Volume: 68, Issue:1

    Topics: Adolescent; Adult; Diarylquinolines; Hearing; Humans; Kanamycin; Middle Aged; Quality of Life; Retrospective Studies; South Africa; Tuberculosis, Multidrug-Resistant; Young Adult

2021
Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis.
    International journal of pharmaceutics, 2017, Aug-07, Volume: 528, Issue:1-2

    Topics: Administration, Inhalation; Aerosols; Cell Line, Tumor; Dry Powder Inhalers; Humans; Kanamycin; Particle Size; Powders; Tuberculosis, Multidrug-Resistant

2017
Impact of
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9

    Topics: Acetyltransferases; Antitubercular Agents; Bacterial Proteins; Base Sequence; Capreomycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Georgia (Republic); Humans; Kanamycin; Mycobacterium tuberculosis; Ofloxacin; Retrospective Studies; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2017
Adaptive gene profiling of Mycobacterium tuberculosis during sub-lethal kanamycin exposure.
    Microbial pathogenesis, 2017, Volume: 112

    Topics: Adaptation, Physiological; Animals; Drug Resistance, Bacterial; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Multigene Family; Mutation; Mutation Rate; Mycobacterium tuberculosis; Protein Interaction Maps; Real-Time Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Tuberculosis, Multidrug-Resistant; Virulence

2017
Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance.
    Diagnostic microbiology and infectious disease, 2017, Volume: 89, Issue:4

    Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Seoul; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant

2017
Applied multiplex allele specific PCR to detect second-line drug resistance among multidrug-resistant tuberculosis in China.
    Tuberculosis (Edinburgh, Scotland), 2017, Volume: 107

    Topics: Antitubercular Agents; Bacteriological Techniques; China; DNA Gyrase; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Mutation; Mycobacterium tuberculosis; Ofloxacin; Predictive Value of Tests; Ribosomal Proteins; Tuberculosis, Multidrug-Resistant

2017
What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2

    Topics: Antitubercular Agents; Bacterial Typing Techniques; Cohort Studies; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genome, Bacterial; Genotype; Humans; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Phenotype; Rifampin; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing

2018
Renal function of MDR-TB patients treated with kanamycin regimens or concomitantly with antiretroviral agents.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2017, 12-01, Volume: 21, Issue:12

    Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Female; Follow-Up Studies; Glomerular Filtration Rate; HIV Infections; Humans; Kanamycin; Kaplan-Meier Estimate; Kidney Function Tests; Male; Middle Aged; Namibia; Proportional Hazards Models; Renal Insufficiency; Retrospective Studies; Tenofovir; Tuberculosis, Multidrug-Resistant; Young Adult

2017
Hearing loss with kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh.
    The European respiratory journal, 2018, Volume: 51, Issue:3

    Topics: Adult; Aminoglycosides; Antitubercular Agents; Bangladesh; Body Mass Index; Cohort Studies; Female; Hearing Loss; Humans; Kanamycin; Kaplan-Meier Estimate; Male; Mycobacterium tuberculosis; Risk Factors; Tuberculosis, Multidrug-Resistant

2018
Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
    BMC infectious diseases, 2018, 02-27, Volume: 18, Issue:1

    Topics: Amikacin; Antitubercular Agents; Base Sequence; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Gene Frequency; Humans; Kanamycin; Microbial Sensitivity Tests; Morocco; Mutation; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Tuberculosis, Multidrug-Resistant

2018
Diagnostic accuracy of GenoType
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2018, 04-01, Volume: 22, Issue:4

    Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; India; Kanamycin; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant

2018
Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Annals of laboratory medicine, 2018, Volume: 38, Issue:4

    Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenotype; Polymerase Chain Reaction; Semiconductors; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant

2018
Risk of Nephrotoxicity in Patients With Drug-Resistant Tuberculosis Treated With Kanamycin/Capreomycin With or Without Concomitant Use of Tenofovir-Containing Antiretroviral Therapy.
    Journal of acquired immune deficiency syndromes (1999), 2018, 08-15, Volume: 78, Issue:5

    Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Capreomycin; Creatinine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kanamycin; Kidney; Male; Retrospective Studies; Tenofovir; Tuberculosis, Multidrug-Resistant

2018
Cycloserine Induced Suicidal Tendencies and Kanamycin Induced Ototoxicity in Indian MDR-TB Patient: A Case Report.
    Current drug safety, 2018, Volume: 13, Issue:3

    Topics: Antitubercular Agents; Cycloserine; Drug Therapy, Combination; Hearing Disorders; Humans; India; Kanamycin; Male; Middle Aged; Suicidal Ideation; Tuberculosis, Multidrug-Resistant

2018
Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain.
    Annals of clinical microbiology and antimicrobials, 2018, Jul-16, Volume: 17, Issue:1

    Topics: Acetyltransferases; Amikacin; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Gene Expression; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Promoter Regions, Genetic; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant

2018
Pyrosequencing: a rapid and effective sequencing method to diagnose drug-resistant tuberculosis.
    Journal of medical microbiology, 2018, Volume: 67, Issue:9

    Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant

2018
Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:12

    Topics: Antitubercular Agents; Clofazimine; Colony Count, Microbial; Computer Simulation; Diarylquinolines; Dose-Response Relationship, Drug; Drug Dosage Calculations; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Host-Pathogen Interactions; Humans; Immunity, Innate; Isoniazid; Kanamycin; Macrophages; Microbial Sensitivity Tests; Models, Statistical; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Pyrazinamide; Time Factors; Tuberculosis, Multidrug-Resistant

2018
Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 10-30, Volume: 69, Issue:10

    Topics: Adult; Antitubercular Agents; Diarylquinolines; Drug Administration Routes; Drug Administration Schedule; Drug Substitution; Female; Humans; Injections; Kanamycin; Male; Middle Aged; Mozambique; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2019
Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya.
    BMC infectious diseases, 2019, Mar-25, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Gene Frequency; Genotype; Humans; Isoniazid; Kanamycin; Kenya; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult

2019
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
    PLoS medicine, 2019, Volume: 16, Issue:4

    Topics: Adult; Antitubercular Agents; Decision Support Techniques; Disease Progression; Drug Administration Schedule; Drug Dosage Calculations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Linezolid; Lung; Male; Middle Aged; Pyrazinamide; Retrospective Studies; Rifampin; Tissue Distribution; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult

2019
Role of M.tuberculosis protein Rv2005c in the aminoglycosides resistance.
    Microbial pathogenesis, 2019, Volume: 132

    Topics: Amikacin; Aminoglycosides; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Protein Interaction Maps; Tuberculosis, Multidrug-Resistant

2019
Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study.
    BMC pharmacology & toxicology, 2019, 05-23, Volume: 20, Issue:1

    Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Capreomycin; Child; Child, Preschool; Creatinine; Ethiopia; Female; HIV Infections; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Ototoxicity; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult

2019
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
    BMC pulmonary medicine, 2019, Jul-10, Volume: 19, Issue:1

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Eswatini; Fluoroquinolones; Gene Frequency; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Sequence Analysis, DNA; Somalia; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Uganda

2019
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:2

    Topics: Acetyltransferases; Amidohydrolases; Amikacin; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Catalase; DNA Gyrase; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genetic Loci; Humans; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Pentosyltransferases; Polymerase Chain Reaction; Promoter Regions, Genetic; Pyrazinamide; Republic of Korea; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant

2013
Predictors of treatment outcome in multidrug-resistant tuberculosis in Portugal.
    The European respiratory journal, 2013, Volume: 42, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Databases, Factual; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Global Health; HIV Infections; Humans; Kanamycin; Male; Middle Aged; Portugal; Regression Analysis; Retrospective Studies; Risk Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult

2013
Salvage therapy for multidrug-resistant tuberculosis.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:5

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Capreomycin; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Male; Moxifloxacin; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Salvage Therapy; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult

2014
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2014
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:4

    Topics: Antitubercular Agents; Bacterial Proteins; Capreomycin; Genotype; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis, Multidrug-Resistant

2014
Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:2

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; India; Kanamycin; Microbial Sensitivity Tests; Microscopy; Moldova; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Peru; Predictive Value of Tests; Reproducibility of Results; South Africa; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2014
Performance of the MTBDRsl assay in Georgia.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:2

    Topics: Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Feasibility Studies; Georgia (Republic); Humans; Kanamycin; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Ofloxacin; Predictive Value of Tests; Reproducibility of Results; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Workflow

2014
Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2014, Volume: 33, Issue:11

    Topics: Amikacin; Antitubercular Agents; Capreomycin; China; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Point Mutation; Tuberculosis, Multidrug-Resistant

2014
Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China.
    Tropical medicine & international health : TM & IH, 2014, Volume: 19, Issue:10

    Topics: Antitubercular Agents; Bacterial Proteins; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genes, Bacterial; Humans; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant

2014
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bangladesh; Child; Clofazimine; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; Humans; Kanamycin; Logistic Models; Male; Middle Aged; Multivariate Analysis; Mycobacterium tuberculosis; Prospective Studies; Pyrazinamide; Risk Factors; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult

2014
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:10

    Topics: Adolescent; Adult; Aged; Body Mass Index; Body Weight; Clofazimine; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Fluoroquinolones; Follow-Up Studies; Gatifloxacin; HIV Infections; Humans; Kanamycin; Male; Middle Aged; Niger; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult

2014
Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1

    Topics: Amikacin; Antibiotics, Antitubercular; Capreomycin; Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2015
Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
    The Indian journal of tuberculosis, 2014, Volume: 61, Issue:4

    Topics: Adolescent; Adult; Aged; Antitubercular Agents; Arthralgia; Ataxia; Chemical and Drug Induced Liver Injury; Child; Cycloserine; Drug Eruptions; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Gastrointestinal Diseases; Hearing Loss; Humans; Hypothyroidism; India; Kanamycin; Levofloxacin; Male; Middle Aged; Peripheral Nervous System Diseases; Psychoses, Substance-Induced; Pyrazinamide; Severity of Illness Index; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Vision Disorders; Young Adult

2014
[Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
    Mikrobiyoloji bulteni, 2015, Volume: 49, Issue:1

    Topics: Acetamides; Antitubercular Agents; Culture Media; Drug Resistance, Multiple, Bacterial; Ethionamide; Humans; Kanamycin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Reagent Strips; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2015
High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2015, Volume: 19, Issue:5

    Topics: Adolescent; Adult; Aged; Antitubercular Agents; Cameroon; Clofazimine; Cohort Studies; Confidence Intervals; Developing Countries; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Isoniazid; Kanamycin; Male; Medication Adherence; Middle Aged; Odds Ratio; Prospective Studies; Prothionamide; Pyrazinamide; Risk Assessment; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult

2015
Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis.
    International journal of antimicrobial agents, 2015, Volume: 46, Issue:3

    Topics: Adult; Amikacin; Antitubercular Agents; Biostatistics; Drug Monitoring; Female; Humans; Kanamycin; Male; Models, Statistical; Retrospective Studies; Specimen Handling; Tuberculosis, Multidrug-Resistant; Young Adult

2015
Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
    BMC pharmacology & toxicology, 2015, Dec-10, Volume: 16

    Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Body Weight; Chi-Square Distribution; Child; Child, Preschool; Coinfection; Hearing Loss; Hearing Tests; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Kanamycin; Logistic Models; Middle Aged; Namibia; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Tuberculosis, Multidrug-Resistant

2015
Novel mutations conferring resistance to kanamycin in Mycobacterium tuberculosis clinical isolates from Northern India.
    Tuberculosis (Edinburgh, Scotland), 2016, Volume: 96

    Topics: 5' Untranslated Regions; Acetyltransferases; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; India; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Polymerase Chain Reaction; Predictive Value of Tests; Promoter Regions, Genetic; Tuberculosis, Multidrug-Resistant

2016
Drug-resistant tuberculosis plagues India.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016, Mar-15, Volume: 188, Issue:5

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; India; Isoniazid; Kanamycin; Medication Adherence; Mycobacterium tuberculosis; Nonprescription Drugs; Rifampin; Tuberculosis, Multidrug-Resistant

2016
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
    International journal of mycobacteriology, 2016, Volume: 5, Issue:1

    Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Genes, rRNA; Genotype; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Promoter Regions, Genetic; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant

2016
Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains.
    Journal of clinical microbiology, 2016, Volume: 54, Issue:6

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Genotyping Techniques; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant

2016
Frequency and Distribution of Tuberculosis Resistance-Associated Mutations between Mumbai, Moldova, and Eastern Cape.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:7

    Topics: Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moldova; Mutation; Mycobacterium tuberculosis; Rifampin; South Africa; Tuberculosis; Tuberculosis, Multidrug-Resistant

2016
Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China.
    Scientific reports, 2016, 05-06, Volume: 6

    Topics: Amikacin; China; Extensively Drug-Resistant Tuberculosis; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant

2016
A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
    The Indian journal of medical research, 2016, Volume: 143, Issue:3

    Topics: Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genotype; Humans; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis, Multidrug-Resistant

2016
Frequency of adverse events observed with second-line drugs among patients treated for multidrug-resistant tuberculosis.
    The Indian journal of tuberculosis, 2016, Volume: 63, Issue:2

    Topics: Adult; Antitubercular Agents; Cohort Studies; Cycloserine; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Humans; Kanamycin; Male; Ofloxacin; Pyrazinamide; Tuberculosis, Multidrug-Resistant; Young Adult

2016
Gitelman-like Syndrome with Kanamycin Toxicity.
    The Journal of the Association of Physicians of India, 2016, Volume: 64, Issue:5

    Topics: Adult; Alkalosis; Anti-Bacterial Agents; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Hypokalemia; Kanamycin; Moxifloxacin; Muscle Cramp; Potassium; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2016
Surveillance for tuberculosis in a rural community in The Philippines.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:11

    Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Isoniazid; Kanamycin; Male; Middle Aged; Philippines; Population Surveillance; Prevalence; Prospective Studies; Public Health; Rifampin; Rural Population; Streptomycin; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant; Young Adult

2016
Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy.
    Auris, nasus, larynx, 2017, Volume: 44, Issue:4

    Topics: Adult; Age Factors; Aminoglycosides; Antitubercular Agents; Audiometry, Pure-Tone; Body Mass Index; Coinfection; Comorbidity; Cycloserine; Diabetes Mellitus; Female; Hearing Loss; HIV Infections; Humans; Kanamycin; Levofloxacin; Male; Middle Aged; Nigeria; Prospective Studies; Prothionamide; Pyrazinamide; Risk Factors; Time Factors; Tuberculosis, Multidrug-Resistant; Young Adult

2017
Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:2

    Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; France; Humans; Kanamycin; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant

2017
Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin.
    Indian journal of experimental biology, 2009, Volume: 47, Issue:6

    Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Streptomycin; Tuberculosis, Multidrug-Resistant

2009
Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2009, Volume: 13, Issue:9

    Topics: Antitubercular Agents; Bacteriological Techniques; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; India; Isoniazid; Kanamycin; Male; Microscopy, Fluorescence; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Prevalence; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant

2009
High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Georgia (Republic); Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant

2009
Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.
    Proceedings of the National Academy of Sciences of the United States of America, 2009, Nov-24, Volume: 106, Issue:47

    Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Promoter Regions, Genetic; Transcription, Genetic; Tuberculosis, Multidrug-Resistant

2009
Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:1

    Topics: Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Genotype; Humans; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pentosyltransferases; Phenotype; Polymerase Chain Reaction; Predictive Value of Tests; RNA, Bacterial; RNA, Ribosomal, 16S; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant

2012
Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:1

    Topics: Antitubercular Agents; Colorimetry; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nitrate Reductase; Ofloxacin; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant

2012
Risk factors associated with kanamycin-resistant tuberculosis in a Beijing tuberculosis referral hospital.
    Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Child, Preschool; China; Female; Hospitals; Humans; Kanamycin; Kanamycin Resistance; Male; Middle Aged; Mycobacterium tuberculosis; Retrospective Studies; Risk Factors; Tuberculosis, Multidrug-Resistant; Young Adult

2012
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
    BMJ case reports, 2012, May-08, Volume: 2012

    Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant

2012
Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.
    Journal of clinical microbiology, 2012, Volume: 50, Issue:9

    Topics: Adolescent; Adult; Aged; Antitubercular Agents; Capreomycin; Child; Cluster Analysis; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Molecular Typing; Mycobacterium tuberculosis; Ofloxacin; South Africa; Tuberculosis, Multidrug-Resistant; Young Adult

2012
Consistency of standard laboratory strain Mycobacterium tuberculosis H 37 Rv with ethionamide susceptibility testing.
    The Indian journal of medical research, 2012, Volume: 135, Issue:5

    Topics: Drug Resistance, Microbial; Ethionamide; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Multidrug-Resistant

2012
Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates.
    Tuberculosis (Edinburgh, Scotland), 2012, Volume: 92, Issue:5

    Topics: Antitubercular Agents; Drug Resistance, Bacterial; Female; Humans; India; Kanamycin; Kanamycin Resistance; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Prevalence; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2012
Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Adult; Anti-Retroviral Agents; CD4 Lymphocyte Count; Cohort Studies; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; HIV Infections; Humans; Isoniazid; Kanamycin; Male; Prevalence; Rifampin; South Africa; Sputum; Streptomycin; Tuberculosis, Multidrug-Resistant

2012
The decline of high drug resistance rate of pulmonary Mycobacterium tuberculosis isolates from a southern Taiwan medical centre, 1996-2000.
    International journal of antimicrobial agents, 2003, Volume: 21, Issue:3

    Topics: Antitubercular Agents; Cycloserine; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Retrospective Studies; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2003
[THE PROBLEM OF INFECTION WITH DRUG-RESISTANT MICROORGANISMS-TUBERCULOSIS].
    [Sogo rinsho] Clinic all-round, 1963, Volume: 12

    Topics: Aminosalicylic Acid; Aminosalicylic Acids; Drug Resistance; Drug Resistance, Microbial; Isoniazid; Japan; Kanamycin; Statistics as Topic; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

1963
RE-TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS AT BATTEY STATE HOSPITAL.
    The American review of respiratory disease, 1964, Volume: 90

    Topics: Aminosalicylic Acid; Aminosalicylic Acids; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethambutol; Ethionamide; Geriatrics; Hospitals, State; Isoniazid; Kanamycin; Pyrazinamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin

1964
THE USE OF ETHIONAMIDE IN COMBINED DRUG REGIMENS IN THE RE-TREATMENT OF ISONIAZID-RESISTANT PULMONARY TUBERCULOSIS.
    The American review of respiratory disease, 1965, Volume: 91

    Topics: Adolescent; Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Cycloserine; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Ethionamide; Hepatomegaly; Isoniazid; Kanamycin; Liver Function Tests; Pharmacology; Pyrazinamide; Toxicology; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Viomycin

1965
[The treatment of streptomycin-resistant pulmonary tuberculosis with kanamycin].
    Kekkaku : [Tuberculosis], 1960, Volume: 35

    Topics: Anti-Bacterial Agents; Kanamycin; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

1960
[M. tuberculosis drug resistance and occurrence in patients with pulmonary tuberculosis].
    Likars'ka sprava, 2003, Issue:8

    Topics: Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Incidence; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Retrospective Studies; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Ukraine

2003
[Etiopathogenetic therapy in adolescent patients with drug-resistant Mycobacterium tuberculosis in respiratory tuberculosis].
    Problemy tuberkuleza i boleznei legkikh, 2004, Issue:1

    Topics: Adolescent; Anti-Bacterial Agents; Genotype; Humans; Isoniazid; Kanamycin; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2004
Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2004, Volume: 8, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminosalicylic Acid; Antitubercular Agents; Cohort Studies; Cycloserine; Female; Humans; Kanamycin; Korea; Male; Middle Aged; Ofloxacin; Prothionamide; Pyrazinamide; Retrospective Studies; Self Administration; Streptomycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2004
[Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Problemy tuberkuleza i boleznei legkikh, 2004, Issue:7

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ozone; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2004
[A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar].
    Archives de l'Institut Pasteur de Madagascar, 2003, Volume: 69, Issue:1-2

    Topics: Amikacin; Antitubercular Agents; Capreomycin; Chronic Disease; Ciprofloxacin; Cough; DNA, Bacterial; Drug Therapy, Combination; Ethionamide; Humans; Kanamycin; Madagascar; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium bovis; Ofloxacin; Patient Compliance; Polymorphism, Restriction Fragment Length; Sputum; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2003
[Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
    Problemy tuberkuleza i boleznei legkikh, 2007, Issue:2

    Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Mice; Mice, Inbred BALB C; Middle Aged; Mycobacterium tuberculosis; Ozone; Radiography, Thoracic; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2007
[Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
    Problemy tuberkuleza i boleznei legkikh, 2007, Issue:5

    Topics: Adolescent; Amikacin; Antitubercular Agents; Child; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Male; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2007
Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2008, Volume: 12, Issue:2

    Topics: Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Ethionamide; Female; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rwanda; Tuberculosis, Multidrug-Resistant

2008
Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1998, Volume: 2, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antitubercular Agents; Child; Drug Resistance, Microbial; Female; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Rifampin; Thailand; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

1998
[Effectiveness of the surgical treatment of patients with pulmonary tuberculosis and multidrug resistance of its causative agent].
    Problemy tuberkuleza, 2000, Issue:4

    Topics: Antibiotics, Antitubercular; Antitubercular Agents; Data Interpretation, Statistical; Drug Resistance, Microbial; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Mycobacterium tuberculosis; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2000
[A case of multidrug-resistant pulmonary tuberculosis].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2000, Volume: 38, Issue:8

    Topics: Administration, Inhalation; Adult; Antibiotics, Antitubercular; Female; Humans; Kanamycin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2000
Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2002, Volume: 6, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Audiometry; Child; Creatinine; Female; Hearing Loss, Bilateral; Humans; Kanamycin; Kidney; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Streptomycin; Time Factors; Tuberculosis; Tuberculosis, Multidrug-Resistant

2002